[4-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxythiophen-2-yl]-morpholin-4-ylmethanone
C21H23N7O3S — CID 155510991
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxythiophen-2-yl]-morpholin-4-ylmethanone
[4-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxythiophen-2-yl]-morpholin-4-ylmethanone (PubChem CID 155510991) has the molecular formula C21H23N7O3S and a molecular weight of 453.53 g/mol. Its IUPAC name is [4-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxythiophen-2-yl]-morpholin-4-ylmethanone.
Molecular Properties
| Compound Name | [4-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxythiophen-2-yl]-morpholin-4-ylmethanone |
|---|---|
| PubChem CID | 155510991 |
| Molecular Formula | C21H23N7O3S |
| Molecular Weight | 453.53 g/mol |
| Exact Mass | 453.16 |
| IUPAC Name | [4-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxythiophen-2-yl]-morpholin-4-ylmethanone |
| SMILES | CCn1ncc(-c2nc3c(Oc4csc(C(=O)N5CCOCC5)c4)ncnc3n2C)c1C |
| InChI | InChI=1S/C21H23N7O3S/c1-4-28-13(2)15(10-24-28)18-25-17-19(26(18)3)22-12-23-20(17)31-14-9-16(32-11-14)21(29)27-5-7-30-8-6-27/h9-12H,4-8H2,1-3H3 |
| InChIKey | XZICPUZVXHICOX-UHFFFAOYSA-N |
| XLogP | 2.88 |
| TPSA | 100.19 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 453.53 |
| LogP ≤ 5 | 2.88 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155510991 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.